People Search
Phones, Emails, Addresses, Background check, Web references
All public info
Like other search engines (Google or Bing) Radaris collects information from public sources.
... Institute, Inc. NIPRO CORPORATION was offered a third party allocation of new shares from ReproCELL Inc. (head office in Minato-ku, Tokyo, represented by Chikafumi Yokoyama, CEO) and ...
Chikafumi Yokoyama Chief Executive Officer, ReproCELL, Inc. Abstract ES/iPS cell-related business will be organically diversified into cell therapy, drug discovery, personalized ...
/ Chikafumi Yokoyama; 14:00-15:30: BIO-4 Forefront of Vaccine Development –Competition Accelerated by Influenza– Avian, Swine, and Pandemic Influenza
Primarily, there is no current alignment between universities and corporations, said Dr Chikafumi Yokoyama, president of Japan's Stem Cell and Drug Discovery Institute.
ReproCELL, Inc. http://www.reprocell.net/ (English) President (Dr. Chikafumi Yokoyama, Ph.D.) Established in February 2003 Capital stock： USD1,537,900 Reprocell's ...
... Institute, Inc. NIPRO CORPORATION was offered a third party allocation of new shares from ReproCELL Inc. (head office in Minato-ku, Tokyo, represented by Chikafumi Yokoyama ...
Chikafumi Yokoyama Chief Executive Officer, ReproCELL, Inc. Abstract ES/iPS cell-related business will be organically diversified into cell therapy, drug discovery ...
/ Chikafumi Yokoyama; 14:00-15:30: BIO-4 Forefront of Vaccine Development –Competition Accelerated by Influenza– Avian, Swine, and Pandemic Influenza
Linkedin